Evidence in Patent Litigation: Navigating Proportionality Requirements, Experts, Scope, Timing, and RFPs

Ms. Prescott’s practice focuses on patent and trade secret litigation with an emphasis on software, network and internet technologies. Ms. Prescott has experience before U.S. district courts nationwide and she has handled all aspects of litigation, including pre-suit investigations, complaint preparation, fact and expert discovery, claim construction, summary judgment hearings, mediations, trial, design around, injunction contingency planning, and appeal. Her experience also includes leading large joint defense groups, coordinating multi-jurisdictional litigation, and negotiating litigation settlements.

Mr. Tulin concentrates his practice on complex litigation and arbitration involving patents, patent licensing disputes, copyrights, and trade secrets in the fields of biochemical processes, pharmaceutical products, medical devices, electrical engineering, semiconductors, computer engineering and software, mechanical engineering, environmental engineering and business methods. Mr. Tulin also has extensive experience with IP licensing and diligence matters, including patent portfolio analyses, freedom-to-operate opinions and contract drafting. In addition, Mr. Tulin is admitted to practice before the USPTO, where he has been involved with reexamination, interference and inter partes review proceedings, including multiple PTAB trials.

Mr. Zapadka counsels clients on the protection and enforcement of their intellectual property assets, with a focus on patent litigation. In this role, he advises on various intellectual property disputes in federal district court and state court, as well as trials at the USPTO Patent Trial and Appeal Board (PTAB). Mr. Zapadka also advises clients on patent prosecution matters, assisting companies ranging in size from start-ups to Fortune 500 companies. Additionally, he has experience litigating commercial disputes. Mr. Zapadka has worked with companies across a variety of sectors, including genetic technologies; biomolecular engineering, such as therapeutic and diagnostic molecules; prosthetics; pharmaceuticals; dietary supplements; cannabis/CBD; nuclear reactors; software; ultracapacitors; consumer products; genetic data visualization systems; and blockchain applications.